CompletedNCT02845453
Quetiapine Added to Usual Care for Youth With Mood and Substance Use Challenges
About this title
Read the official source — NCT02845453Medication studyAges 15–24United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 15 years to 24 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: January 20, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- Boston Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 15 Years to 24 Years
- Official registry ID
- NCT02845453
- Official title
Show the full official title
A Randomized Controlled Trial of Quetiapine for the Treatment of Youth With Co-occurring Substance Use Disorders and Severe Mood Dysregulation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Boston Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine.
Who was this study for?
Listed age limits: 15 years to 24 years.
